Nothing Special   »   [go: up one dir, main page]

DK3084009T3 - Lactobacillus salivarius til behandling af mastitis - Google Patents

Lactobacillus salivarius til behandling af mastitis Download PDF

Info

Publication number
DK3084009T3
DK3084009T3 DK14828344.3T DK14828344T DK3084009T3 DK 3084009 T3 DK3084009 T3 DK 3084009T3 DK 14828344 T DK14828344 T DK 14828344T DK 3084009 T3 DK3084009 T3 DK 3084009T3
Authority
DK
Denmark
Prior art keywords
mastitis
treatment
lactobacillus salivarius
salivarius
lactobacillus
Prior art date
Application number
DK14828344.3T
Other languages
English (en)
Inventor
Rocio Martin
Jan Knol
Martos Irene Espinosa
Quintana Esther Antonia Jiménez
Gómez Juan Miguel Rodríguez
Álvarez Leonides Fernández
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutricia Nv filed Critical Nutricia Nv
Application granted granted Critical
Publication of DK3084009T3 publication Critical patent/DK3084009T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/14Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK14828344.3T 2013-12-19 2014-12-19 Lactobacillus salivarius til behandling af mastitis DK3084009T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/NL2013/050924 WO2015093937A1 (en) 2013-12-19 2013-12-19 Lactobacillus salivarius for the treatment of mastitis
PCT/NL2014/050890 WO2015093963A1 (en) 2013-12-19 2014-12-19 Lactobacillus salivarius for the treatment of mastitis

Publications (1)

Publication Number Publication Date
DK3084009T3 true DK3084009T3 (da) 2019-07-15

Family

ID=50001228

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14828344.3T DK3084009T3 (da) 2013-12-19 2014-12-19 Lactobacillus salivarius til behandling af mastitis

Country Status (15)

Country Link
US (1) US10420807B2 (da)
EP (1) EP3084009B1 (da)
CN (1) CN106103695B (da)
AU (1) AU2014367412B2 (da)
DK (1) DK3084009T3 (da)
ES (1) ES2734204T3 (da)
HU (1) HUE044330T2 (da)
MY (1) MY186323A (da)
NZ (1) NZ720901A (da)
PH (1) PH12016501087A1 (da)
PL (1) PL3084009T3 (da)
PT (1) PT3084009T (da)
RU (1) RU2684600C1 (da)
TR (1) TR201910280T4 (da)
WO (2) WO2015093937A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109310705A (zh) * 2016-03-18 2019-02-05 加拿大农业及农业食品部 干奶时加速乳腺退化和预防乳腺感染的方法
EP3517119B1 (en) 2018-01-26 2021-08-11 Probisearch, S.L.U. Composition comprising new lactobacillus salivarius strain and method for the prevention and treatment of otitis and upper respiratory infections
RU2709970C1 (ru) * 2019-07-05 2019-12-23 Илья Владимирович Кукес Способ лечения и профилактики острых и хронических форм мастита у животных
WO2021095476A1 (ja) * 2019-11-11 2021-05-20 株式会社ヤクルト本社 オリゴ糖を含む発酵乳の製造方法
CN115725443B (zh) * 2019-11-14 2024-07-05 内蒙古蒙牛乳业(集团)股份有限公司 一株鼠李糖乳杆菌及其应用
EP4065146A1 (en) * 2019-11-29 2022-10-05 Société des Produits Nestlé S.A. Compositions and methods with a probiotic and a nutrient and/or mineral for the prevention or treatment of mastitis
CA3161666A1 (en) * 2019-11-29 2021-06-03 Societe Des Produits Nestle S.A. Compositions and methods for the treatment of mastitis
RU2726653C2 (ru) * 2019-12-26 2020-07-15 Федеральное государственное бюджетное учреждение науки Оренбургский федеральный исследовательский центр Уральского отделения Российской академии наук Штамм бактерий Lactobacillus salivarius - продуцент ингибитора цитокинов интерлейкина-6 и интерлейкина-17
US20230040010A1 (en) * 2020-01-16 2023-02-09 Societe Des Produits Nestle S.A. Compositions and methods for the treatment of mastitis
CN113981116A (zh) * 2021-11-30 2022-01-28 广州舒客实业有限公司 用于快速鉴定唾液乳杆菌的特异性引物、试剂盒及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1565547T4 (da) * 2002-06-28 2013-01-14 Biosearch S A Probiotiske stammer, en fremgangsmåde til selektion deraf, præparater deraf samt anvendelse deraf
EP1997499A1 (en) * 2007-05-31 2008-12-03 Puleva Biotech, S.A. Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
EP2551279A1 (en) * 2011-07-27 2013-01-30 University College Cork Antimicrobial peptide produced by intestinal Lactobacillus salivarius

Also Published As

Publication number Publication date
TR201910280T4 (tr) 2019-07-22
AU2014367412B2 (en) 2021-03-11
ES2734204T3 (es) 2019-12-04
NZ720901A (en) 2022-11-25
HUE044330T2 (hu) 2019-10-28
EP3084009B1 (en) 2019-04-10
PH12016501087B1 (en) 2016-07-11
PH12016501087A1 (en) 2016-07-11
RU2684600C1 (ru) 2019-04-09
EP3084009A1 (en) 2016-10-26
US20170027997A1 (en) 2017-02-02
US10420807B2 (en) 2019-09-24
MY186323A (en) 2021-07-09
WO2015093937A1 (en) 2015-06-25
WO2015093963A1 (en) 2015-06-25
RU2016129178A (ru) 2018-01-24
AU2014367412A1 (en) 2016-07-07
CN106103695B (zh) 2020-12-01
PL3084009T3 (pl) 2019-09-30
CN106103695A (zh) 2016-11-09
PT3084009T (pt) 2019-07-17

Similar Documents

Publication Publication Date Title
DK2954051T3 (da) Modificeret kapsid til genoverførsel til behandling af nethinden
DK3851537T5 (da) Behandling af hyperbilirubinæmi
DK3611262T3 (da) Fremgangsmåder til sekvensering af immunrepertoire
DK2968208T3 (da) Behandling af kataplexi
DK2964315T3 (da) System til behandling af neuromotorisk dysfunktion
DK3084009T3 (da) Lactobacillus salivarius til behandling af mastitis
DK2986722T3 (da) Manipulerede phenylalaninammoniak-lyasepolypeptider
DK3099298T3 (da) Kombinationsterapier med zidovudin til behandling af mikrobielle infektioner
DK3010895T3 (da) Fremgangsmåde til fremstilling af 4-propargyleret aminobenzoxazinoner
DK2992104T3 (da) Fremgangsmåde til ekspression
FI20145100L (fi) Magneetti
DK3498235T3 (da) Krum sål
DK2943561T3 (da) Fotobioreaktor
DK2961378T3 (da) Fremgangsmåder til behandlingen af mitochondrisk sygdom
DE112015003671A5 (de) Befeuchter
FR3025617B1 (fr) Architecture bi-voies
DK3371293T3 (da) Fermentering
MA41266A (fr) Cataplasme
FI20145103L (fi) Magneetti
FI20136184L (fi) Menetelmä maidon käsittelemiseksi
FR3024647B1 (fr) Transat de puericulture
DK3030272T3 (da) Fremgangsmåde til enzymatisk behandling af vævsprodukter
DK2976101T3 (da) Behandlingsfremgangsmåde
DK3200783T3 (da) Behandling af erytromelalgi
DK3014164T3 (da) Kanalsaneringsfremgangsmåde